# Delivery Order #SPE2DR26FBQDQ

DMS Pharmaceutical Group Xolair Delivery Order

**Buyer:** Defense Logistics Agency

**Award Amount:** $3,494.88
**Ceiling:** $3,494.88

**Awarded:** July 07, 2026
**Period of Performance:** Jul 07, 2026 - Jul 28, 2026

**Identifier:** SPE2DR26FBQDQ
**NAICS:** 424210

This delivery order, issued under an existing indefinite-delivery contract, procures Xolair 300 mg/2 mL autoinjectors for the Pharmaceutical PV Division. DMS Pharmaceutical Group Inc., a pharmaceutical distributor, is responsible for supplying the medication; no parent company information or further delivery requirements are provided. The order supports the agency’s pharmaceutical supply needs by providing a specified prescription treatment. The underlying supply contract runs on a multi-year basis, and this order has a short performance period. The order was placed in 2026 under parent contract SPE2DR25D9304. The available data does not identify whether the parent contract was competitively awarded or sole-source, provide an original solicitation, acquisition program, or subcontractors, or describe related prior contracts.

### Description

4572340051!XOLAIR 300 MG/2 ML AUTOINJECT 2ML

[View original record](https://www.usaspending.gov/award/CONT_AWD_SPE2DR26FBQDQ_9700_SPE2DR25D9304_9700)
